Clinical Trials List
2024-07-31 - 2035-12-31
Phase III
Recruiting3
ICD-10K50.90
Crohn's disease, unspecified, without complications
ICD-10K50.911
Crohn's disease, unspecified, with rectal bleeding
ICD-10K50.918
Crohn's disease, unspecified, with other complication
ICD-10K50.919
Crohn's disease, unspecified, with unspecified complications
ICD-9555.9
Regional enteritis, unspecified site
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 黃詮博 Digestive System Department
- 張鈺屏 Digestive System Department
- SHU-CHEN WEI Digestive System Department
- 林弘堯 Digestive System Department
- 魏銘漢 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳嘉峯 Division of Pediatrics
- CHIEN-CHIH TUNG Division of Family Medicine
- 吳心耘 Digestive System Department
- Huey-Ling Chen Division of Pediatrics
- 凃佳宏 Digestive System Department
- YEN-HSUAN NI Division of Pediatrics
- 謝銘鈞 Division of Hematology & Oncology
- 翁孟慈 醫學研究部
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Jung Kuo Digestive System Department
- 許振銘 Digestive System Department
- Cheng-Yu Lin Digestive System Department
- Cheng-Tang Chiu Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
1200 participants
